DK1754713T3 - Peptider, der binder sig til Apo2L (Trail)-receptorer samt anvendelser deraf - Google Patents
Peptider, der binder sig til Apo2L (Trail)-receptorer samt anvendelser derafInfo
- Publication number
- DK1754713T3 DK1754713T3 DK06013626T DK06013626T DK1754713T3 DK 1754713 T3 DK1754713 T3 DK 1754713T3 DK 06013626 T DK06013626 T DK 06013626T DK 06013626 T DK06013626 T DK 06013626T DK 1754713 T3 DK1754713 T3 DK 1754713T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptides
- bind
- apo2l
- trail
- receptors
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 abstract 3
- 108700012411 TNFSF10 Proteins 0.000 abstract 3
- 230000004071 biological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46943603P | 2003-05-09 | 2003-05-09 | |
PCT/US2004/013576 WO2004101608A2 (en) | 2003-05-09 | 2004-04-29 | Apo2l (trail) receptor binding peptides and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1754713T3 true DK1754713T3 (da) | 2009-06-08 |
Family
ID=33452286
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06013626T DK1754713T3 (da) | 2003-05-09 | 2004-04-29 | Peptider, der binder sig til Apo2L (Trail)-receptorer samt anvendelser deraf |
DK04760861T DK1622929T3 (da) | 2003-05-09 | 2004-04-29 | Apo-2L (TRAIL) receptorbindingspeptider og anvendelser deraf |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04760861T DK1622929T3 (da) | 2003-05-09 | 2004-04-29 | Apo-2L (TRAIL) receptorbindingspeptider og anvendelser deraf |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070066800A1 (da) |
EP (2) | EP1622929B1 (da) |
JP (1) | JP2007530008A (da) |
AT (2) | ATE342274T1 (da) |
AU (1) | AU2004238794A1 (da) |
CA (1) | CA2524456A1 (da) |
DE (2) | DE602004002773T2 (da) |
DK (2) | DK1754713T3 (da) |
ES (2) | ES2322182T3 (da) |
IL (1) | IL171733A (da) |
PL (2) | PL1622929T3 (da) |
WO (1) | WO2004101608A2 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007530588A (ja) | 2004-03-23 | 2007-11-01 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | レセプターカップリング剤およびその治療用途 |
US20060188498A1 (en) * | 2005-02-18 | 2006-08-24 | Genentech, Inc. | Methods of using death receptor agonists and EGFR inhibitors |
US20090131317A1 (en) * | 2007-06-22 | 2009-05-21 | Affymax, Inc. | Compounds and peptides that bind the trail receptor |
JP2012522492A (ja) * | 2009-04-03 | 2012-09-27 | インスティテュート オブ ベーシック メディカル サイエンシズ チャイニーズ アカデミー オブ メディカル サイエンシズ | 抗ヒトデスレセプターdr5モノクローナル抗体ad5−10により認識される抗原決定基、その誘導体およびその使用 |
WO2011043835A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Polypeptides that bind il-23r |
WO2015138638A1 (en) | 2014-03-11 | 2015-09-17 | Theraly Pharmaceuticals, Inc. | Long acting trail receptor agonists for treatment of autoimmune diseases |
FR3031112B1 (fr) * | 2014-12-24 | 2018-05-25 | Eyevensys | Construction d'adn pour le traitement de pathologies oculaires |
CN105061604B (zh) * | 2015-08-19 | 2018-03-16 | 河南大学 | sDR5‑Fc融合蛋白突变体及其应用 |
EA038551B1 (ru) | 2015-12-17 | 2021-09-14 | Дзе Джонс Хопкинс Юниверсити | Способ лечения или профилактики системного склероза |
JP7281795B2 (ja) | 2016-04-07 | 2023-05-26 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 膵炎および疼痛をデス受容体アゴニストで処置するための組成物および方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6252050B1 (en) * | 1998-06-12 | 2001-06-26 | Genentech, Inc. | Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
-
2004
- 2004-04-29 DK DK06013626T patent/DK1754713T3/da active
- 2004-04-29 ES ES06013626T patent/ES2322182T3/es not_active Expired - Lifetime
- 2004-04-29 ES ES04760861T patent/ES2274480T3/es not_active Expired - Lifetime
- 2004-04-29 PL PL04760861T patent/PL1622929T3/pl unknown
- 2004-04-29 WO PCT/US2004/013576 patent/WO2004101608A2/en active IP Right Grant
- 2004-04-29 JP JP2006532534A patent/JP2007530008A/ja active Pending
- 2004-04-29 EP EP04760861A patent/EP1622929B1/en not_active Expired - Lifetime
- 2004-04-29 DK DK04760861T patent/DK1622929T3/da active
- 2004-04-29 CA CA002524456A patent/CA2524456A1/en not_active Abandoned
- 2004-04-29 PL PL06013626T patent/PL1754713T3/pl unknown
- 2004-04-29 AT AT04760861T patent/ATE342274T1/de active
- 2004-04-29 AU AU2004238794A patent/AU2004238794A1/en not_active Abandoned
- 2004-04-29 DE DE602004002773T patent/DE602004002773T2/de not_active Expired - Lifetime
- 2004-04-29 US US10/556,106 patent/US20070066800A1/en not_active Abandoned
- 2004-04-29 DE DE602004019701T patent/DE602004019701D1/de not_active Expired - Lifetime
- 2004-04-29 EP EP06013626A patent/EP1754713B1/en not_active Expired - Lifetime
- 2004-04-29 AT AT06013626T patent/ATE423786T1/de active
-
2005
- 2005-11-02 IL IL171733A patent/IL171733A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE602004002773D1 (de) | 2006-11-23 |
PL1754713T3 (pl) | 2009-07-31 |
DE602004002773T2 (de) | 2007-08-16 |
WO2004101608A2 (en) | 2004-11-25 |
EP1622929B1 (en) | 2006-10-11 |
EP1754713B1 (en) | 2009-02-25 |
IL171733A (en) | 2010-11-30 |
ATE423786T1 (de) | 2009-03-15 |
ATE342274T1 (de) | 2006-11-15 |
AU2004238794A1 (en) | 2004-11-25 |
DK1622929T3 (da) | 2007-02-19 |
PL1622929T3 (pl) | 2007-03-30 |
US20070066800A1 (en) | 2007-03-22 |
WO2004101608A3 (en) | 2004-12-29 |
ES2274480T3 (es) | 2007-05-16 |
JP2007530008A (ja) | 2007-11-01 |
CA2524456A1 (en) | 2004-11-25 |
EP1622929A2 (en) | 2006-02-08 |
DE602004019701D1 (de) | 2009-04-09 |
ES2322182T3 (es) | 2009-06-17 |
EP1754713A1 (en) | 2007-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112840T1 (el) | Πρωτεϊνες συντηξης ταci-ανοσοσφαιρινης | |
IL171733A (en) | Apo2l (trail) receptor binding peptides and uses thereof | |
DE60325892D1 (de) | Stellungs- und verwendungsverfahren | |
ATE309347T1 (de) | Protocadherin-proteine und verwendungen davon | |
DK1450847T3 (da) | Apo2-ligand/TRAIL-formuleringer og anvendelser deraf | |
DK1536778T3 (da) | Proteiner, der binder til cross-beta-strukturholdigt amyloid og fremgangsmåder til modulation af cross-beta-strukturen, dens dannelse og dens associerede toksicitet | |
EA200800301A1 (ru) | Протеины, связывающие il-6 | |
CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του | |
SE0202725D0 (sv) | Anordning för magnetiskt inducerbar membrantransport |